UiPath Inc(PATH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 20.64 | EPS (ttm) | 0.67 | Insider Own | 22.89% | Shs Outstand | 456.3M | Perf Week | -22.9% |
| Market Cap | 7.23B | Forward P/E | 15.02 | EPS next Y | 17.58% | Insider Trans | -1.21% | Shs Float | 399.5M | Perf Month | -11.77% |
| Enterprise Value | 6.02B | PEG | 1.08 | EPS next Q | 0.19 | Inst Own | 68.78% | Short Float | 29.51% | Perf Quarter | 29.02% |
| Income | 0.36B | P/S | 4.2 | EPS this Y | 9.11% | Inst Trans | 9.98% | Short Ratio | 1.69 | Perf Half Y | 12.04% |
| Sales | 1.72B | P/B | 3.71 | EPS next 5Y | 13.96% | ROA | 13.16% | Short Interest | 117.88M | Perf YTD | -15.38% |
| Book/sh | 3.74 | P/C | 5.62 | EPS past 3/5Y | - | ROE | 20.03% | 52W High | -30.09% ($19.84) | Perf Year | 19.47% |
| Cash/sh | 2.47 | P/FCF | 19.92 | Sales past 3/5Y | 15.01% 21.53% | ROIC | 17.93% | 52W Low | 50.76% ($9.20) | Perf 3Y | -24.95% |
| Dividend Est. | - | EV/EBITDA | 32.31 | EPS Y/Y TTM | 1765.75% | Gross Margin | 82.14% | Volatility(W/M) | 7.88% 5.68% | Perf 5Y | -74.94% |
| Dividend TTM | - | EV/Sales | 3.5 | Sales Y/Y TTM | 14.98% | Oper. Margin | 9.37% | ATR (14) | 1.01 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.28 | EPS Q/Q | 2279.31% | Profit Margin | 21.03% | RSI (14) | 39.55 | Recom | 2.74 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.28 | Sales Q/Q | 13.42% | SMA20 | -15.55% ($16.42) | Beta | 1.01 | Target Price | $17.37 |
| Payout | - | Debt/Eq | 0.04 | Earnings | 2026/9/3 | SMA50 | -1.51% ($14.08) | Rel Volume | 0.92 | Prev Close | $13.57 |
| Employees | 3981 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 1.01% 3.14% | SMA200 | 7.52% ($12.9) | Avg Volume(3M) | 69.62M | Price | $13.87 |
| IPO | 2021/4/21 | Option/Short | Yes/Yes | Trades | 84241 | Volume | 64,265,519 | Change | 2.21% |
Company
PATH is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🤖 This is a U.S. technology company that provides business automation software. At its core, the company offers a platform for automating repetitive tasks previously handled by humans using software robots, and it is expanding its scope into intelligent automation and agents powered by artificial intelligence. It is an infrastructure software stock whose performance is tied to subscription revenue and the expansion of its enterprise customer base.
Over the past 1 year, roughly in the middle
30% below its 1-year high.
PATH makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.1% this year.
Tap to view numbers
The stock looks undervalued
Trading at 20.6 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -24.9% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Short interest is a burden
Institutions hold 68.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
INVN 0.02%
AVRY 0.02%
FTKI 0.02%
BUZZ 0.02%
GRNJ 0.01%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
PATX 4MIt ranks #4 in the industry
Based on market cap of $7B.
PATH $7B PER 20.6
MSFT $3.7T PER 27.4
ORCL $441B PER 26.3
PLTR $399B PER 141.8
FAQ
What kind of company is PATH?
PATH belongs to the Technology sector and operates in the Software - Infrastructure industry.
What is the market cap of PATH?
The market cap of PATH is approximately $7.2B, ranking 1,122 within its sector.
What is the P/E ratio of PATH?
PATH has a P/E ratio of approximately 20.6x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for PATH?
PATH has recorded a 52-week high of $19.84 and a low of $9.20.
